[go: up one dir, main page]

ES528001A0 - A PROCEDURE TO FRACTIONATE SERUM ANTIBODIES. - Google Patents

A PROCEDURE TO FRACTIONATE SERUM ANTIBODIES.

Info

Publication number
ES528001A0
ES528001A0 ES528001A ES528001A ES528001A0 ES 528001 A0 ES528001 A0 ES 528001A0 ES 528001 A ES528001 A ES 528001A ES 528001 A ES528001 A ES 528001A ES 528001 A0 ES528001 A0 ES 528001A0
Authority
ES
Spain
Prior art keywords
procedure
serum antibodies
fractionate
fractionate serum
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528001A
Other languages
Spanish (es)
Other versions
ES8706964A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES528001A0 publication Critical patent/ES528001A0/en
Publication of ES8706964A1 publication Critical patent/ES8706964A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES528001A 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies. Expired ES8706964A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES528001A0 true ES528001A0 (en) 1987-07-01
ES8706964A1 ES8706964A1 (en) 1987-07-01

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Expired ES8404858A1 (en) 1982-04-12 1983-04-11 Method of affinity purification employing monoclonal antibodies.
ES528001A Expired ES8706964A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.
ES528000A Expired ES8506902A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521371A Expired ES8404858A1 (en) 1982-04-12 1983-04-11 Method of affinity purification employing monoclonal antibodies.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES528000A Expired ES8506902A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.

Country Status (11)

Country Link
EP (1) EP0105359A4 (en)
AT (1) AT393386B (en)
AU (1) AU622099B2 (en)
CA (1) CA1209907A (en)
CH (1) CH672028A5 (en)
DK (1) DK192191A (en)
ES (3) ES8404858A1 (en)
FI (1) FI88403C (en)
GB (1) GB2128630B (en)
IT (1) IT1219779B (en)
WO (1) WO1983003678A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (en) * 1987-03-06 1993-02-22 Perstorp Biolytica ADSORBENT FOR ISOCRATIC AFFINITY CHROMATOGRAPHY
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
WO1989000695A1 (en) * 1987-07-14 1989-01-26 The Victoria University Of Manchester Method for the diagnosis of infections with detection of lipopolysaccharide antigens
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
EP0937146A2 (en) * 1996-09-20 1999-08-25 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
WO2009125825A1 (en) * 2008-04-11 2009-10-15 中外製薬株式会社 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
EP4231014A3 (en) 2010-11-30 2024-08-14 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
CA2827923C (en) 2011-02-25 2021-11-23 Chugai Seiyaku Kabushiki Kaisha Fc.gamma.riib-specific fc antibody
JP6322411B2 (en) 2011-09-30 2018-05-09 中外製薬株式会社 Antigen-binding molecules that promote the disappearance of antigens with multiple physiological activities
CN104080909A (en) 2011-11-30 2014-10-01 中外制药株式会社 A drug that contains a transporter (carrier) that enters cells to form immune complexes
CN107207607B (en) 2014-12-19 2021-05-04 中外制药株式会社 Anti-C5 antibodies and methods of use
TWI808330B (en) 2014-12-19 2023-07-11 日商中外製藥股份有限公司 ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT Fc REGIONs, AND METHODS OF USE
JP7141336B2 (en) 2015-12-25 2022-09-22 中外製薬株式会社 Anti-myostatin antibodies and methods of use
RU2766112C2 (en) 2016-08-05 2022-02-08 Чугаи Сейяку Кабусики Кайся Composition for prevention or treatment of il-8-related diseases
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (en) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Purification method of Fc fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
WO1982002818A1 (en) * 1981-02-26 1982-09-02 Gani Mohamed Mutwahar A process and apparatus for the recovery of immunoglobulins
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
IT1219779B (en) 1990-05-24
EP0105359A4 (en) 1984-08-20
ATA901983A (en) 1991-03-15
IT8320550A0 (en) 1983-04-12
FI88403B (en) 1993-01-29
ES521371A0 (en) 1984-05-16
CH672028A5 (en) 1989-10-13
GB2128630B (en) 1986-08-28
FI834530A0 (en) 1983-12-09
FI88403C (en) 1993-05-10
ES8404858A1 (en) 1984-05-16
DK192191D0 (en) 1991-11-26
FI834530L (en) 1983-12-09
WO1983003678A1 (en) 1983-10-27
GB8332644D0 (en) 1984-01-11
ES528000A0 (en) 1985-08-01
GB2128630A (en) 1984-05-02
AU7256987A (en) 1987-09-03
DK192191A (en) 1991-11-26
CA1209907A (en) 1986-08-19
AU622099B2 (en) 1992-04-02
ES8706964A1 (en) 1987-07-01
EP0105359A1 (en) 1984-04-18
ES8506902A1 (en) 1985-08-01
AT393386B (en) 1991-10-10

Similar Documents

Publication Publication Date Title
ES528001A0 (en) A PROCEDURE TO FRACTIONATE SERUM ANTIBODIES.
DE3382572D1 (en) ANTIBODY CONNECTIONS.
ES527140A0 (en) A PROCEDURE TO MANUFACTURE A HIGH INTEGRITY CONTAINER.
ES528627A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLO-AND PIRIDAZO-PIRAZOLINAS, -PIRIDAZINAS Y-DIAZEPINAS.
FI840090L (en) HYBRID PROTEINS.
DK90482A (en) MODIFIED ORGANOFILE LER COMPLEX
ES526849A0 (en) A PROCEDURE FOR PRODUCING A MODIFIED PROTEIN ADHESIVE BINDER
NO159251C (en) STAPLER.
ES506969A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRIMIDINAS SUBSTITUTES-IDAS.
ES501645A0 (en) A PROCEDURE FOR THE PREPARATION OF 6-ALQUILIDEN-PENAMAS.
ES505464A0 (en) A PROCEDURE FOR THE PREPARATION OF N-HETEROCICLILAMINOCARBONIL ARILSULFONAMIDAS.
ES520730A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOLACTAMAS.
DK52483D0 (en) IMMUNOASSAY
FI833792A7 (en) Stapler.
ES526402A0 (en) A METHOD FOR THE PREPARATION OF NEW POLYPEPTIDES.
ES507506A0 (en) A PROCEDURE FOR THE PREPARATION OF IMIDAZOLYLPHENYLAMI-DINAS.
ES503307A0 (en) A PROCEDURE FOR THE PREPARATION OF QUINOXALINYLOXIETERS.
ES506216A0 (en) A PROCEDURE FOR THE PREPARATION OF 2-GUANIDINO-4-HETEROARIL-TIAZOLES.
ES522120A0 (en) A PROCEDURE FOR THE PREPARATION OF 4-ARYL-4-PIPERIDINCARBINOLS.
FI73942B (en) A UTLOESARE MANOEVRERBAR FOERDELNINGSVENTIL FOER EN UNDER TRYCK STAOENDE BEHAOLLARE.
ES524460A0 (en) A METHOD OF IMMUNO ASSAY.
ES520759A0 (en) A DEOXYGENATION PROCESS.
ES522221A0 (en) A PROCEDURE FOR THE PREPARATION OF POLYPEPTIDES.
ES535727A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW PEPTIDES.
ES522186A0 (en) ANTIBODY TEST METHOD.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201